FDAnews Drug Daily Bulletin

CELLARTIS AB RAISES EUR 8 MILLION FOR THE DEVELOPMENT OF HUMAN FUNCTIONAL CELLS

Dec. 14, 2005
A A

Cellartis AB is pleased to announce the successful completion of a financing round led by a new investor, Bio Fund Management Ltd of Finland (BioFund). Existing shareholders, InnovationsKapital, Catella Healthcare Investments, T-bolaget, Texcel and Barnwik AB, also participated in the financing round.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1125201XSL_NEWSML_TO_NEWSML_WEB.xml)